Mesoblast (MESO) Research & Development (2014 - 2023)
Mesoblast's Research & Development came in at -$97.51 million for the year ended Jun 30, 2026, compared with -$34.81 million a year earlier.
Powered by 
Analysis
Mesoblast (MESO) Research & Development (2014 - 2023) Analysis & Trends
Going back to the year ended Jun 30, 2015, Mesoblast's Research & Development data covers 12 years.
- The figure for the year ended Jun 30, 2026 represents the lowest annual Research & Development in data going back to the year ended Jun 30, 2015.
- Per Business Quant, earlier years put Research & Development at -$34.81 million in the year ended Jun 30, 2025, -$39.72 million in the year ended Jun 30, 2024, -$52.82 million in the year ended Jun 30, 2023 and -$32.82 million in the year ended Jun 30, 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Mesoblast | 1.84 Bn | 1.40 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 32.32 Mn |
| Mar 31, 2023 | 7.07 Mn |
| Dec 31, 2022 | 7.68 Mn |
| Sep 30, 2022 | 5.74 Mn |
| Jun 30, 2022 | 5.04 Mn |
| Mar 31, 2022 | 8.25 Mn |
| Dec 31, 2021 | 10.20 Mn |
| Sep 30, 2021 | 9.33 Mn |
| Jun 30, 2021 | 7.06 Mn |
| Mar 31, 2021 | 12.44 Mn |
| Dec 31, 2020 | 14.24 Mn |
| Sep 30, 2020 | 19.28 Mn |
| Jun 30, 2020 | 15.27 Mn |
| Mar 31, 2020 | 14.38 Mn |
| Dec 31, 2019 | 14.15 Mn |
| Sep 30, 2019 | 12.39 Mn |
| Jun 30, 2019 | 11.44 Mn |
| Mar 31, 2019 | 14.41 Mn |
| Dec 31, 2018 | 15.49 Mn |
| Sep 30, 2018 | 18.49 Mn |
API Access
Mesoblast Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();